Journal of International Medical Research (Nov 2024)

Sjögren’s syndrome positive for isolated anti-Ro52/SS-A antibody and anti-centromere antibody

  • Hideki Nakamura,
  • Masako Tsukamoto,
  • Kinya Nagata,
  • Yosuke Nagasawa,
  • Kumiko Akiya,
  • Hirotake Inomata,
  • Masahiro Nishihara,
  • Shin-Ya Asatani,
  • Noboru Kitamura,
  • Hisataka Kitano,
  • Jun Shoji,
  • Yu Iwabuchi,
  • Toshiyuki Ishige,
  • Hiroyuki Hao

DOI
https://doi.org/10.1177/03000605241293986
Journal volume & issue
Vol. 52

Abstract

Read online

This current case report describes a Japanese woman in her 80s with xerostomia who presented with salivary gland dysfunction. She was positive for isolated anti-Ro52/SS-A antibody as determined by a chemiluminescent enzyme immunoassay and positive on a fluorescence enzyme immunoassay that recognizes both Ro52 and Ro60 antigens. A high serum concentration of anti-Ro52/SS-A antibody was determined by an enzyme-linked immunosorbent assay. A high anti-centromere antibodies (ACA) titre was also observed. Although Raynaud’s phenomenon or a high serum immunoglobulin G concentration were not observed, Masson-trichrome staining of the patient’s labial salivary glands showed considerable fibrosis. Her serum type I and type II interferon concentrations were normal. The present patient is the first with Sjögren’s syndrome (SS) to exhibit isolated anti-Ro52/SS-A antibody and ACA without anti-Ro60/SS-A antibody. This current case report presents her case together with those of four other SS patients who were positive for isolated anti-Ro52/SS-A antibody. The SS literature also includes cases positive for ACA and describes clinical characteristics. The other four SS patients with isolated anti-Ro52/SS-A antibody described here had no ACA; interstitial pneumonia and polyneuropathy were observed in these cases, although there was no consistent tendency regarding types I and II interferon.